A new trading day began on Friday, with Castle Biosciences Inc (NASDAQ: CSTL) stock price up 3.04% from the previous day of trading, before settling in for the closing price of $19.75. CSTL’s price has ranged from $15.45 to $35.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -517.12%. With a float of $27.94 million, this company’s outstanding shares have now reached $28.84 million.
Let’s determine the extent of company efficiency that accounts for 761 employees. In terms of profitability, gross margin is 85.88%, operating margin of -3.97%, and the pretax margin is -0.64%.
Castle Biosciences Inc (CSTL) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Castle Biosciences Inc is 3.21%, while institutional ownership is 91.53%. The most recent insider transaction that took place on Jun 27 ’25, was worth 344,566. Before that another transaction happened on Apr 21 ’25, when Company’s Pres. & Chief Exec. Officer sold 4,408 for $21.52, making the entire transaction worth $94,851. This insider now owns 4,275 shares in total.
Castle Biosciences Inc (CSTL) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.63 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -517.12% per share during the next fiscal year.
Castle Biosciences Inc (NASDAQ: CSTL) Trading Performance Indicators
Here are Castle Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.69. Likewise, its price to free cash flow for the trailing twelve months is 12.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.20, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.96 in one year’s time.
Technical Analysis of Castle Biosciences Inc (CSTL)
Looking closely at Castle Biosciences Inc (NASDAQ: CSTL), its last 5-days average volume was 0.56 million, which is a jump from its year-to-date volume of 0.46 million. As of the previous 9 days, the stock’s Stochastic %D was 92.45%.
During the past 100 days, Castle Biosciences Inc’s (CSTL) raw stochastic average was set at 36.51%, which indicates a significant decrease from 93.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.69% in the past 14 days, which was lower than the 50.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.24, while its 200-day Moving Average is $25.06. However, in the short run, Castle Biosciences Inc’s stock first resistance to watch stands at $20.71. Second resistance stands at $21.08. The third major resistance level sits at $21.60. If the price goes on to break the first support level at $19.82, it is likely to go to the next support level at $19.30. Now, if the price goes above the second support level, the third support stands at $18.93.
Castle Biosciences Inc (NASDAQ: CSTL) Key Stats
With a market capitalization of 587.55 million, the company has a total of 28,872K Shares Outstanding. Currently, annual sales are 332,070 K while annual income is 18,250 K. The company’s previous quarter sales were 87,990 K while its latest quarter income was -25,850 K.
